Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Supervised lifestyle intervention from a medical professional may help maximize fat loss and minimize muscle tissue loss in people taking the potent weight loss drugs.

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

GLP-1s have become game changers for millions of Americans trying to lose weight and improve their health. (Photo illustration: Yahoo News, photos: Getty Images) ...

This might mean decreasing the risk for diabetes or high cholesterol, two conditions that are common in people with PCOS. Research backs this up: when using GLP-1s to aid in weight loss ...

Pharma giant Novo Nordisk, which makes the obesity drug Wegovy, says the widespread availability of copycat medications is hurting sales and that is “taking legal actions” to protect its ...

While Lilly's success with GLP-1 drugs is certainly impressive, I have my eyes on another area of the company this year. Let's dig into what Lilly's business looks like beyond weight loss ...

and included over 162,000 patients split into matched pairs (meaning: one control subject, one experimental subject). Not all GLP-1 drugs had the same psychiatric effects: Ozempic was associated ...